These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29734454)

  • 1. The Efficacy of Neutral Position Beractant Administration in Neonates.
    Kovey K; Barnes K; Beckett RD; Rice M
    Am J Perinatol; 2018 Nov; 35(13):1303-1307. PubMed ID: 29734454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Three Different Administration Positions for Intratracheal Beractant in Preterm Newborns with Respiratory Distress Syndrome.
    Karadag A; Ozdemir R; Degirmencioglu H; Uras N; Dilmen U; Bilgili G; Erdeve O; Cakir U; Atasay B
    Pediatr Neonatol; 2016 Apr; 57(2):105-12. PubMed ID: 26190853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
    Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome.
    Malloy CA; Nicoski P; Muraskas JK
    Acta Paediatr; 2005 Jun; 94(6):779-84. PubMed ID: 16188788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
    J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beractant and calfactant in a neonatal intensive care unit.
    Hastings LK; Renfro WH; Sharma R
    Am J Health Syst Pharm; 2004 Feb; 61(3):257-60. PubMed ID: 14986555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodevelopmental outcomes of very low birth weight preterm infants treated with poractant alfa versus beractant for respiratory distress syndrome.
    Eras Z; Dizdar EA; Kanmaz G; Guzoglu N; Aksoy HT; Altunkaya GB; Canpolat FE; Dilmen U
    Am J Perinatol; 2014 Jun; 31(6):463-8. PubMed ID: 23884719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome.
    Zola EM; Gunkel JH; Chan RK; Lim MO; Knox I; Feldman BH; Denson SE; Stonestreet BS; Mitchell BR; Wyza MM
    J Pediatr; 1993 Mar; 122(3):453-9. PubMed ID: 8441105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.
    Ramanathan R; Rasmussen MR; Gerstmann DR; Finer N; Sekar K;
    Am J Perinatol; 2004 Apr; 21(3):109-19. PubMed ID: 15085492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study.
    Paul S; Rao S; Kohan R; McMichael J; French N; Zhang G; Simmer K
    J Paediatr Child Health; 2013 Oct; 49(10):839-44. PubMed ID: 23802801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for use of beractant (Survanta) in neonates.
    Rogers R; Mirro R; Korones SB
    Clin Pharm; 1992 Apr; 11(4):357-9. PubMed ID: 1563235
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calfactant: a review of its use in neonatal respiratory distress syndrome.
    Onrust SV; Dooley M; Goa KL
    Paediatr Drugs; 1999; 1(3):219-43. PubMed ID: 10937453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome.
    Köksal N; Akpinar R; Cetinkaya M
    Turk J Pediatr; 2009; 51(6):556-64. PubMed ID: 20196389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
    Bloom BT; Kattwinkel J; Hall RT; Delmore PM; Egan EA; Trout JR; Malloy MH; Brown DR; Holzman IR; Coghill CH; Carlo WA; Pramanik AK; McCaffree MA; Toubas PL; Laudert S; Gratny LL; Weatherstone KB; Seguin JH; Willett LD; Gutcher GR; Mueller DH; Topper WH
    Pediatrics; 1997 Jul; 100(1):31-8. PubMed ID: 9200357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of laryngeal mask airway versus endotracheal intubation for surfactant delivery.
    Pinheiro JM; Santana-Rivas Q; Pezzano C
    J Perinatol; 2016 Mar; 36(3):196-201. PubMed ID: 26633145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Investigational New Drug experience with Survanta (beractant).
    Zola EM; Overbach AM; Gunkel JH; Mitchell BR; Nagle BT; DeMarco NG; Henwood GA; Gold AJ
    Pediatrics; 1993 Mar; 91(3):546-51. PubMed ID: 8441557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.